Department ChairDivision of Hematology and Oncology, Shizuoka Children’s HospitalShizuoka, Shizuoka, Japan
OC 50.4 - Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in hemophilia A with inhibitor (UNEBI Study): Multicenter open-label non-randomized trial.
Tuesday, June 25, 202410:15 – 10:30 ICT
